BGLAP and type 2 diabetes mellitus: Serum markers of bone formation such as osteocalcin (OCN) and amino-terminal propeptide of procollagen type 1 (P1NP) have been found decreased in T2DM patients [11–13], supporting the hypothesis that bone formation is lower than in controls.